Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis
- PMID: 37149128
- DOI: 10.1016/j.otoeng.2022.10.009
Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis
Abstract
Objective: Patients with head and neck squamous cell carcinoma (HNSCC) have an increased risk of second esophageal neoplasms. The aim of the present study is to evaluate the incidence, risk factors and prognosis of second esophageal neoplasms in patients with HNSCC.
Methods: A retrospective study of 4711 patients with index tumor in the oral cavity, oropharynx, hypopharynx or larynx between 1985 and 2020 was conducted.
Results: During the period analysed 149 patients (3.2%) had a second esophageal neoplasm. The incidence of second esophageal neoplasia was 0.42% per year and remained nearly constant throughout the follow-up period. According to the results of a multivariate study, the risk factors related to the appearance of second esophageal neoplasms were a history of high alcohol consumption and the location of the primary tumor in the oropharynx or hypopharynx. The 5-year disease-specific survival rate in patients with a second esophageal neoplasm, calculated from the diagnosis of this second neoplasm, was 10.5%.
Conclusions: Patients with a HNSCC have an increased risk of developing of a second esophageal neoplasm. The risk factors associated with the appearance of a second esophageal neoplasm were severe alcohol consumption and the location of the primary tumor in the oropharynx or hypopharynx.
Keywords: Cáncer de cabeza y cuello; Cáncer de esófago; Esophageal cancer; Factores de riesgo; Head and neck cancer; Risk factors; Second neoplasm; Segunda neoplasia; Supervivencia; Survival.
Copyright © 2023 Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.Int J Cancer. 2017 Nov 15;141(10):1987-1996. doi: 10.1002/ijc.30911. Epub 2017 Aug 9. Int J Cancer. 2017. PMID: 28758200
-
Association of esophageal squamous cell carcinoma with head and neck cancer.Gastroenterol Hepatol. 2025 May;48(5):502318. doi: 10.1016/j.gastrohep.2024.502318. Epub 2024 Dec 9. Gastroenterol Hepatol. 2025. PMID: 39662764 English, Spanish.
-
Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.Scand J Gastroenterol. 2014 Dec;49(12):1486-92. doi: 10.3109/00365521.2013.832369. Epub 2014 Nov 5. Scand J Gastroenterol. 2014. PMID: 25372595 Clinical Trial.
-
Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):40-5. doi: 10.1001/jamaoto.2015.2815. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 26633039 Review.
-
Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma.Med Sci (Basel). 2023 Jun 13;11(2):42. doi: 10.3390/medsci11020042. Med Sci (Basel). 2023. PMID: 37367741 Free PMC article. Review.
Cited by
-
Clinicopathologic characteristics of HPV-associated head and neck squamous cell carcinoma in Southern China: long-term retrospective study of 400 cases.Ther Adv Med Oncol. 2024 Apr 11;16:17588359241242962. doi: 10.1177/17588359241242962. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38617023 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical